Jan Booij

发表

Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease

Gerda Andringa, Benjamin Drukarch, John G. J. M. Bol, 2005, NeuroImage.

3-D Rat Brain Phantom for High-Resolution Molecular Imaging

Frans van der Have, Brendan Vastenhouw, Marcia Vervloet, 2009, Proceedings of the IEEE.

[123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods

Michel Koole, Andrea Varrone, Robin de Nijs, 2017, EJNMMI Physics.

Structural, functional and molecular imaging of the brain in primary focal dystonia—A review

Aart J. Nederveen, Jan Booij, E. Zoons, 2011, NeuroImage.

Value of Semiquantitative Analysis for Clinical Reporting of 123 I-2-b-Carbomethoxy-3b-(4-Iodophenyl)-N-(3-Fluoropropyl)

Flavio Nobili, Paul Kemp, Jan Booij, 2013 .

I-123-FP-CIT pharmacokinetics and dosimetry show great potential for the evaluation of dopamine transporter system in clinical routine

Jan Booij, Dc Costa, Cle Katona, 1996 .

Mapping the hemodynamic response in human subjects to a dopaminergic challenge with dextroamphetamine using ASL-based pharmacological MRI

Aart J. Nederveen, Liesbeth Reneman, Matthan W. A. Caan, 2013, NeuroImage.

No association between striatal dopamine transporter binding and body mass index: A multi-center European study in healthy volunteers

Marco Pagani, Gitte Moos Knudsen, Koen Van Laere, 2013, NeuroImage.

Pharmacokinetics and dosimetry of FP-CIT a new ligand to study the pre-synaptic transporter system

Jan Booij, Durval C. Costa, Wendy Waddington, 1996 .

Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: A head-to-head comparison with 15O H2O positron emission tomography

Aart J. Nederveen, Esben Thade Petersen, Matthias J. P. van Osch, 2014, NeuroImage.

Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies

Jacques Darcourt, Cornelia Reininger, Jan Booij, 2009, British Journal of Psychiatry.

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review

Jan Booij, R. D. de Haan, R. D. de Bie, 2015, EJNMMI Research.

Reduction in camera-specific variability in [123I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific binding ratio in the ENC-DAT database of healthy controls

Claus Svarer, John Dickson, Andrea Varrone, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Repeated administration of D-amphetamine induces loss of [123I]FP-CIT binding to striatal dopamine transporters in rat brain: a validation study.

Jan Booij, J. Booij, K. D. de Bruin, 2006, Nuclear medicine and biology.

Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques

Jan J Piek, Jan Booij, Esther Lutgens, 2017, PloS one.

Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults.

Jan Booij, Maartje M L de Win, 2006, Nuclear medicine and biology.

Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia

Paras Lakhani, Jan Booij, P. Lakhani, 2017, The Journal of Nuclear Medicine.

For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

Liesbeth Reneman, Wim van den Brink, Jan Booij, 2022 .

SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0*

John Seibyl, Karl Herholz, Osama Sabri, 2012, The Journal of Nuclear Medicine.

A Prospective Cohort Study on Sustained Effects of Low-Dose Ecstasy Use on the Brain in New Ecstasy Users

Liesbeth Reneman, Cristina Lavini, Wim van den Brink, 2007, Neuropsychopharmacology.

Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible.

Cristina Lavini, Jan Booij, Gerard J den Heeten, 2003, Nuclear medicine and biology.

Validity of [123I]β‐CIT SPECT in detecting MDMA‐induced serotonergic neurotoxicity

Liesbeth Reneman, Jan Booij, G. D. den Heeten, 2002, Synapse.

EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2

Koen Van Laere, Jacques Darcourt, Kjell Någren, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls

Liesbeth Reneman, Diederick Stoffers, Jan Booij, 2015, Brain Imaging and Behavior.

Rigidity and bradykinesia reduce interlimb coordination in Parkinsonian gait.

Jan Booij, R. Wagenaar, J. Booij, 2005, Archives of physical medicine and rehabilitation.

Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123I-Ioflupane Injection (DaTscan) Imaging

Jacques Darcourt, Jan Booij, Andreas Kupsch, 2014, The Journal of Nuclear Medicine.

Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECT

Jan Booij, Oliver Pogarell, Wolfgang H Oertel, 2009, Movement disorders : official journal of the Movement Disorder Society.

Proposal for the standardisation of multi-centre trials in nuclear medicine imaging: prerequisites for a European 123I-FP-CIT SPECT database

Markus Nowak Lonsdale, Felicia Zito, Livia Tossici-Bolt, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2

Koen Van Laere, Jacques Darcourt, Kjell Någren, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

dopaminergic degeneration in early stage Parkinson's disease

Jan Booij, J. C. Stoof, E. Wolters, 2006 .

Cerebral blood flow changes during script-driven imagery in police officers with posttraumatic stress disorder

Gerard J. den Heeten, Miranda Olff, Jan Booij, 2004, Biological Psychiatry.

Reduced dopamine transporter binding predates impulse control disorders in Parkinson's disease

Jan Booij, Tommy Pattij, Chris Vriend, 2014, Movement disorders : official journal of the Movement Disorder Society.

Striatal Dopamine Transporter Availability Associated with Polymorphisms in the Dopamine Transporter Gene SLC6A3

Frank Baas, Jan Booij, Wim van den Brink, 2008, Journal of Nuclear Medicine.

SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.

Jan Booij, J. Booij, R. Knol, 2007, Parkinsonism & related disorders.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder

Remco J. Renken, Sebastiaan Overeem, Karl Kesper, 2017, Movement disorders : official journal of the Movement Disorder Society.

Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway

Jan Booij, Henk W. Berendse, H. Berendse, 2011, Journal of the Neurological Sciences.

VECTor: A Preclinical Imaging System for Simultaneous Submillimeter SPECT and PET

Brendan Vastenhouw, Frans van der Have, Freek J Beekman, 2013, The Journal of Nuclear Medicine.

Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males.

Jan Booij, Dick J Veltman, Wim van den Brink, 2009, Drug and alcohol dependence.

Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls

Jacques Darcourt, Andrea Varrone, Markus Diemling, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Neuroimaging essentials in essential tremor: A systematic review

Aart J. Nederveen, Jan Booij, Sarvi Sharifi, 2014, NeuroImage: Clinical.

Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs

Jan Booij, Paul Kemp, J. Booij, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2

Jacques Darcourt, Kjell Någren, Andrea Varrone, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

Serotonin transporter binding with [123I]β-CIT SPECT in major depressive disorder versus controls: effect of season and gender

Jan Booij, Johannes B. Reitsma, A. Schene, 2009, European Journal of Nuclear Medicine and Molecular Imaging.

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging

Koen Van Laere, Jacques Darcourt, Andrea Varrone, 2017, EJNMMI Research.

Value of Semiquantitative Analysis for Clinical Reporting of 123I-2-β-Carbomethoxy-3β-(4-Iodophenyl)-N-(3-Fluoropropyl)Nortropane SPECT Studies

Osama Sabri, Flavio Nobili, John C Dickson, 2013, The Journal of Nuclear Medicine.

123I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M1 In Vivo

Geor Bakker, David A. Collier, Vanessa N. Barth, 2015, The Journal of Nuclear Medicine.

Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes

Jacques Darcourt, Andrea Varrone, Markus Diemling, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters

Michael G. Stabin, Jan Booij, Ellinor Busemann Sokole, 1997, European Journal of Nuclear Medicine.

Gender differences in Parkinson’s disease

Bastiaan R Bloem, George F Borm, Jan Booij, 2006, Journal of Neurology, Neurosurgery & Psychiatry.

The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI

Freek J. Beekman, Roel Van Holen, Marion de Jong, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects

Liesbeth Reneman, Jan Booij, Wim van den Brink, 2006, Journal of psychopharmacology.

The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: A review

Wim van den Brink, Jan Booij, Michelle L. Miller, 2010, European Neuropsychopharmacology.

Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease

Diederick Stoffers, Jan Booij, Mirthe M Ponsen, 2009, Journal of Neurology, Neurosurgery & Psychiatry.

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism

Jan Booij, J. Booij, E. V. van Royen, 1999, European Journal of Nuclear Medicine.

The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism

Jan Booij, Johannes D. Speelman, E. Wolters, 2001, European Journal of Nuclear Medicine.

Iodine-123-N-ω-Fluoropropyl-2β-Carbomethoxy-3β-(4-Iodophenyl)Tropane SPECT in Healthy Controls and Early-Stage, Drug-Naive Parkinson's Disease

Jan Booij, E. A. Van Royen, J. C. Stoof, 1998 .

The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease.

Jan Booij, Kora de Bruin, Sven R. Suwijn, 2014, Parkinsonism & related disorders.

Validity of in vivo [123I]β-CIT SPECT in detecting MDMA-induced neurotoxicity in rats

Liesbeth Reneman, Jan Booij, L. Reneman, 2004, European Neuropsychopharmacology.

Clinical Applications of [123I]FP-CIT SPECT Imaging

Jan Booij, Henk W. Berendse, Marina A. J. Tijssen, 2014, PET and SPECT in Neurology.